115 related articles for article (PubMed ID: 8496919)
1. N-(arylalkyl)farnesylamines: new potent squalene synthetase inhibitors.
Prashad M; Kathawala FG; Scallen T
J Med Chem; 1993 May; 36(10):1501-4. PubMed ID: 8496919
[No Abstract] [Full Text] [Related]
2. Amidinium cation as a mimic of allylic carbocation: synthesis and squalene synthetase inhibitory activity of an amidinium analog of a carbocation intermediate.
Prashad M
J Med Chem; 1993 Mar; 36(5):631-2. PubMed ID: 8496942
[No Abstract] [Full Text] [Related]
3. Inhibition of squalene synthetase by farnesyl pyrophosphate analogues.
de Montellano PR; Wei JS; Castillo R; Hsu CK; Boparai A
J Med Chem; 1977 Feb; 20(2):243-9. PubMed ID: 189031
[TBL] [Abstract][Full Text] [Related]
4. Discovery of a new 2-aminobenzhydrol template for highly potent squalene synthase inhibitors.
Ichikawa M; Yokomizo A; Itoh M; Usui H; Shimizu H; Suzuki M; Terayama K; Kanda A; Sugita K
Bioorg Med Chem; 2011 Mar; 19(6):1930-49. PubMed ID: 21353782
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of prenyl alcohols by terpenoid biosynthesis inhibitors in various microorganisms.
Muramatsu M; Ohto C; Obata S; Sakuradani E; Shimizu S
Appl Microbiol Biotechnol; 2008 Sep; 80(4):589-95. PubMed ID: 18636253
[TBL] [Abstract][Full Text] [Related]
6. (1 alpha, 2 beta, 3 beta, 4 alpha)-1,2-bis[N-propyl-N-(4-phenoxybenzyl) amino]carbonyl]cyclobutane-3,4-dicarboxylic acid (A-87049): a novel potent squalene synthase inhibitor.
Fung AK; Baker WR; Fakhoury S; Stein HH; Cohen J; Donner BG; Garvey DS; Spina KP; Rosenberg SH
J Med Chem; 1997 Jul; 40(14):2123-5. PubMed ID: 9216829
[No Abstract] [Full Text] [Related]
7. Squalene synthase inhibitors suppress triglyceride biosynthesis through the farnesol pathway in rat hepatocytes.
Hiyoshi H; Yanagimachi M; Ito M; Yasuda N; Okada T; Ikuta H; Shinmyo D; Tanaka K; Kurusu N; Yoshida I; Abe S; Saeki T; Tanaka H
J Lipid Res; 2003 Jan; 44(1):128-35. PubMed ID: 12518031
[TBL] [Abstract][Full Text] [Related]
8. Cyclopentanedi- and tricarboxylic acids as squalene synthase inhibitors: syntheses and evaluation.
Shen W; Garvey DS; Cohen J; Stein H; Rosenberg SH
Bioorg Med Chem Lett; 1998 Apr; 8(8):891-6. PubMed ID: 9871507
[TBL] [Abstract][Full Text] [Related]
9. Identification and optimization of tetrahydro-2H-3-benzazepin-2-ones as squalene synthase inhibitors.
Griebenow N; Flessner T; Buchmueller A; Raabe M; Bischoff H; Kolkhof P
Bioorg Med Chem Lett; 2011 Apr; 21(8):2554-8. PubMed ID: 21396815
[TBL] [Abstract][Full Text] [Related]
10. Stereochemistry-dependent inhibition of RAS farnesylation by farnesyl phosphonic acids.
Hohl RJ; Lewis KA; Cermak DM; Wiemer DF
Lipids; 1998 Jan; 33(1):39-46. PubMed ID: 9470172
[TBL] [Abstract][Full Text] [Related]
11. The squalene synthetase active site. Catalytic acceptance of 7- and 11- demethylfarnesyl pyrophosphates.
Ortiz de Montellano PR; Boparai AS
Biochem Biophys Res Commun; 1976 May; 76(2):520-5. PubMed ID: 800341
[No Abstract] [Full Text] [Related]
12. Inhibitors of squalene biosynthesis and metabolism.
Abe I; Tomesch JC; Wattanasin S; Prestwich GD
Nat Prod Rep; 1994 Jun; 11(3):279-302. PubMed ID: 15200015
[No Abstract] [Full Text] [Related]
13. Syntheses and biological evaluation of novel quinuclidine derivatives as squalene synthase inhibitors.
Ishihara T; Kakuta H; Moritani H; Ugawa T; Sakamoto S; Tsukamoto S; Yanagisawa I
Bioorg Med Chem; 2003 May; 11(11):2403-14. PubMed ID: 12735986
[TBL] [Abstract][Full Text] [Related]
14. Massive production of farnesol-derived dicarboxylic acids in mice treated with the squalene synthase inhibitor zaragozic acid A.
Vaidya S; Bostedor R; Kurtz MM; Bergstrom JD; Bansal VS
Arch Biochem Biophys; 1998 Jul; 355(1):84-92. PubMed ID: 9647670
[TBL] [Abstract][Full Text] [Related]
15. Phenoxypropylamines: a new series of squalene synthase inhibitors.
Brown GR; Butlin RJ; Chapman S; Eakin MA; Foubister AJ; Freeman S; Griffiths D; Harrison PJ; Johnson MC; Mallion KB
J Med Chem; 1995 Oct; 38(21):4157-60. PubMed ID: 7473541
[No Abstract] [Full Text] [Related]
16. Discovery of novel tricyclic compounds as squalene synthase inhibitors.
Ichikawa M; Ohtsuka M; Ohki H; Haginoya N; Itoh M; Sugita K; Usui H; Suzuki M; Terayama K; Kanda A
Bioorg Med Chem; 2012 May; 20(9):3072-93. PubMed ID: 22464687
[TBL] [Abstract][Full Text] [Related]
17. Identification of 4H,6H-[2]benzoxepino[4,5-c][1,2]oxazoles as novel squalene synthase inhibitors.
Griebenow N; Buchmueller A; Kolkhof P; Schamberger J; Bischoff H
Bioorg Med Chem Lett; 2011 Jun; 21(12):3648-53. PubMed ID: 21576018
[TBL] [Abstract][Full Text] [Related]
18. Letter: Squalene synthetase. Differentiation between the two substrate binding sites by a substrate analogue.
Ortiz de Montellano PR; Castillo R; Vinson W; Wei JS
J Am Chem Soc; 1976 Mar; 98(7):2018-9. PubMed ID: 1254859
[No Abstract] [Full Text] [Related]
19. Identification of novel mammalian squalene synthase inhibitors using a three-dimensional pharmacophore.
Fairlamb IJ; Dickinson JM; O'Connor R; Higson S; Grieveson L; Marin V
Bioorg Med Chem; 2002 Aug; 10(8):2641-56. PubMed ID: 12057653
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of cholesterol synthesis by squalene synthase inhibitors does not induce myotoxicity in vitro.
Flint OP; Masters BA; Gregg RE; Durham SK
Toxicol Appl Pharmacol; 1997 Jul; 145(1):91-8. PubMed ID: 9221828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
